S. Onal And I. Tugal-Tutkun, "Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)," OPHTHALMOLOGY , vol.121, no.10, 2014
Onal, S. And Tugal-Tutkun, I. 2014. Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96). OPHTHALMOLOGY , vol.121, no.10 .
Onal, S., & Tugal-Tutkun, I., (2014). Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96). OPHTHALMOLOGY , vol.121, no.10.
Onal, Sumru, And Nuriye İlknur TUTKUN. "Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)," OPHTHALMOLOGY , vol.121, no.10, 2014
Onal, Sumru And Tugal-Tutkun, Nuriye İ. . "Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)." OPHTHALMOLOGY , vol.121, no.10, 2014
Onal, S. And Tugal-Tutkun, I. (2014) . "Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)." OPHTHALMOLOGY , vol.121, no.10.
@article{article, author={Sumru Onal And author={Nuriye İlknur TUTKUN}, title={Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)}, journal={OPHTHALMOLOGY}, year=2014}